Whether you are in pharmaceuticals, veterinary drugs, medical devices, diagnostics, biotechnology, life sciences research, plant biology, crop science, agriculture, or “border” products such as nutraceuticals, food supplements and food products—Dentons knows your business.

Every day, we help life sciences clients decide how best to face the challenges in developing and commercializing products, delivering services, and capitalizing on scientific breakthroughs and business opportunities around the globe. In addition to our lawyers’ seamless collaboration worldwide, we work closely with research institutes, leaders in scientific opinion, pharma-economic and medical experts and management advisers to provide the well-rounded, commercially focused service you need. 

When you need capital, we are there. Our lawyers have participated in numerous public offerings, venture capital investments, mergers & acquisitions, leveraged buyouts, technology transfer transactions, university spin-offs and initial financing transactions.

Need to capitalize on your innovations? We have structured complex licensing, distribution, co-promotion, development and manufacturing agreements. From research and development through manufacturing, protection of intellectual property and patients’ consent, marketing and sales, we provide the knowledge and support you need to keep projects moving, while mitigating risks to help you steer clear of costly delays and complications.

When compliance issues, investigations, litigation, or problems with anti-gift, anti-corruption and transparency regulations threaten to take you away from the business of improving health, our unparalleled preparation and in-depth knowledge of the law, regulations and your business takes the weight off your shoulders.

Learn more about our Life Sciences sector

Recognition

Dentons recognized for quality in Chambers France 2025

February 7, 2025

In the inaugural edition of Chambers France 2025 guide, Dentons lawyers received 15 individual rankings of which five were new or improved ratings. 

Insights

Dentons Bratislava Life Sciences Newsletter (Slovak)

April 2025

Slovak Republic: We are pleased to present you with a new issue of the Life Sciences Newsletter with interesting events and key news from the decision-making practice of the Ministry of Health of the Slovak Republic and legislation.

Dentons Bratislava Life Sciences Newsletter (Slovak)

March 2025

Slovak Republic: We are pleased to present you with a new issue of the Life Sciences Newsletter with interesting events and key news from the decision-making practice of the Ministry of Health of the Slovak Republic and legislation.

Dentons Bratislava Life Sciences Newsletter (Slovak)

February 2025

Slovak Republic: We are pleased to present you with a new issue of the Life Sciences Newsletter with interesting events and key news from the decision-making practice of the Ministry of Health of the Slovak Republic and legislation.

View all insights for Life Sciences Practice

News and Events

Recent Press Releases

Dentons welcomes Rick Pawluk as a partner in the Corporate group in Calgary

February 18, 2025

Dentons, Canada’s Global Law Firm, is pleased to announce the arrival of Rick Pawluk as a partner in the Corporate group in Calgary.

Dentons Lee Bio Team Introduces the Impact of US Policy Changes on the Biopharmaceutical Industry

October 16, 2024

Dentons Lee’s Bio Team, foreign attorney Bernard K. Ham and senior attorney Peter Seung-Hun Lee introduces the Impact of U.S. Policy Changes on the Biopharmaceutical Industry.